ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/01 | 1,830 | 1,840 | 1,804 | 1,822 | +5 | +0.3% | 293,600 |
| 2021/10/29 | 1,841 | 1,848 | 1,803 | 1,817 | -1 | -0.1% | 249,200 |
| 2021/10/28 | 1,835 | 1,841 | 1,808 | 1,818 | -25 | -1.4% | 326,900 |
| 2021/10/27 | 1,880 | 1,881 | 1,830 | 1,843 | -47 | -2.5% | 389,700 |
| 2021/10/26 | 1,885 | 1,904 | 1,870 | 1,890 | +32 | +1.7% | 277,600 |
| 2021/10/25 | 1,857 | 1,872 | 1,835 | 1,858 | -19 | -1% | 296,100 |
| 2021/10/22 | 1,876 | 1,894 | 1,865 | 1,877 | +3 | +0.2% | 270,300 |
| 2021/10/21 | 1,910 | 1,914 | 1,865 | 1,874 | -44 | -2.3% | 423,100 |
| 2021/10/20 | 1,930 | 1,948 | 1,906 | 1,918 | +8 | +0.4% | 354,300 |
| 2021/10/19 | 1,911 | 1,921 | 1,886 | 1,910 | +14 | +0.7% | 240,100 |
| 2021/10/18 | 1,949 | 1,953 | 1,889 | 1,896 | -48 | -2.5% | 428,100 |
| 2021/10/15 | 1,956 | 1,956 | 1,914 | 1,944 | +9 | +0.5% | 241,600 |
| 2021/10/14 | 1,941 | 1,953 | 1,923 | 1,935 | +9 | +0.5% | 295,900 |
| 2021/10/13 | 1,939 | 1,955 | 1,922 | 1,926 | -18 | -0.9% | 273,300 |
| 2021/10/12 | 1,996 | 2,005 | 1,942 | 1,944 | -45 | -2.3% | 480,200 |
| 2021/10/11 | 1,972 | 1,995 | 1,943 | 1,989 | +12 | +0.6% | 486,900 |
| 2021/10/08 | 1,955 | 2,003 | 1,952 | 1,977 | +34 | +1.7% | 724,700 |
| 2021/10/07 | 1,887 | 1,955 | 1,882 | 1,943 | +87 | +4.7% | 765,600 |
| 2021/10/06 | 1,905 | 1,911 | 1,839 | 1,856 | -26 | -1.4% | 519,900 |
| 2021/10/05 | 1,880 | 1,909 | 1,834 | 1,882 | -27 | -1.4% | 848,600 |
| 2021/10/04 | 1,965 | 1,992 | 1,897 | 1,909 | -27 | -1.4% | 739,100 |
| 2021/10/01 | 1,920 | 1,947 | 1,904 | 1,936 | +31 | +1.6% | 577,600 |
| 2021/09/30 | 1,892 | 1,928 | 1,878 | 1,905 | +23 | +1.2% | 537,000 |
| 2021/09/29 | 1,860 | 1,892 | 1,843 | 1,882 | -15 | -0.8% | 548,100 |
| 2021/09/28 | 1,942 | 1,949 | 1,876 | 1,897 | -61 | -3.1% | 751,800 |
| 2021/09/27 | 1,992 | 1,997 | 1,950 | 1,958 | -30 | -1.5% | 435,800 |
| 2021/09/24 | 1,993 | 2,018 | 1,984 | 1,988 | +35 | +1.8% | 615,400 |
| 2021/09/22 | 1,985 | 2,000 | 1,938 | 1,953 | -33 | -1.7% | 666,800 |
| 2021/09/21 | 1,960 | 2,003 | 1,946 | 1,986 | -36 | -1.8% | 695,800 |
| 2021/09/17 | 1,979 | 2,025 | 1,965 | 2,022 | +43 | +2.2% | 587,300 |
| 2021/09/16 | 2,021 | 2,039 | 1,937 | 1,979 | -70 | -3.4% | 1,157,400 |
| 2021/09/15 | 1,960 | 2,082 | 1,944 | 2,049 | +76 | +3.9% | 1,673,700 |
| 2021/09/14 | 1,930 | 1,979 | 1,924 | 1,973 | +23 | +1.2% | 580,800 |
| 2021/09/13 | 1,930 | 1,965 | 1,911 | 1,950 | +15 | +0.8% | 960,900 |
| 2021/09/10 | 1,955 | 1,955 | 1,917 | 1,935 | +14 | +0.7% | 437,000 |
| 2021/09/09 | 1,936 | 1,951 | 1,916 | 1,921 | -23 | -1.2% | 346,800 |
| 2021/09/08 | 1,929 | 1,970 | 1,918 | 1,944 | -20 | -1% | 676,300 |
| 2021/09/07 | 1,902 | 1,968 | 1,892 | 1,964 | +76 | +4% | 987,200 |
| 2021/09/06 | 1,870 | 1,894 | 1,834 | 1,888 | +29 | +1.6% | 642,700 |
| 2021/09/03 | 1,805 | 1,860 | 1,803 | 1,859 | +75 | +4.2% | 965,100 |
| 2021/09/02 | 1,794 | 1,801 | 1,773 | 1,784 | -10 | -0.6% | 289,800 |
| 2021/09/01 | 1,778 | 1,796 | 1,771 | 1,794 | +22 | +1.2% | 266,000 |
| 2021/08/31 | 1,773 | 1,788 | 1,758 | 1,772 | -8 | -0.4% | 423,500 |
| 2021/08/30 | 1,768 | 1,801 | 1,758 | 1,780 | +12 | +0.7% | 442,100 |
| 2021/08/27 | 1,743 | 1,771 | 1,734 | 1,768 | +27 | +1.6% | 421,000 |
| 2021/08/26 | 1,697 | 1,753 | 1,695 | 1,741 | +56 | +3.3% | 484,100 |
| 2021/08/25 | 1,720 | 1,720 | 1,674 | 1,685 | -40 | -2.3% | 499,500 |
| 2021/08/24 | 1,715 | 1,726 | 1,696 | 1,725 | +14 | +0.8% | 284,900 |
| 2021/08/23 | 1,722 | 1,735 | 1,704 | 1,711 | +25 | +1.5% | 271,400 |
| 2021/08/20 | 1,721 | 1,745 | 1,680 | 1,686 | -39 | -2.3% | 529,600 |
751～
800
件表示中 / 4976件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
